Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort
Juan Berenguer, Cristina Díez, María Martin‐Vicente, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1678-1684
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

HIV and COVID-19: review of clinical course and outcomes
Lauren K. Barbera, Kevin Kamis, Sarah E. Rowan, et al.
HIV Research & Clinical Practice (2021) Vol. 22, Iss. 4, pp. 102-118
Open Access | Times Cited: 63
Systematic Review and Meta-Analyses of The Interaction Between HIV Infection And COVID-19: Two Years’ Evidence Summary
Yehua Wang, Yewei Xie, Siyue Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
Anaïs Corma‐Gómez, Marta Fernández‐Fuertes, Estefania García, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 11, pp. 1492-1498
Open Access | Times Cited: 30
Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
Jianhui Yang, Esben Strodl, Dandan Zhang, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment
Julia del Amo, Rosa Polo, Santiago Moreno, et al.
AIDS (2021) Vol. 36, Iss. 2, pp. 161-168
Open Access | Times Cited: 31
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Francisco Javier Candel, Pablo Barreiro, Miguel Salavert, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1449-1449
Open Access | Times Cited: 11
Clinical epidemiology of COVID‐19 in people of black ethnicity living with HIV in the UK
Zoë Ottaway, Lucy Campbell, Laura Cechin, et al.
HIV Medicine (2024) Vol. 25, Iss. 5, pp. 614-621
Open Access | Times Cited: 3
Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level
Chiara Acchioni, Silvia Sandini, Marta Acchioni, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 349-349
Open Access | Times Cited: 3
Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection
Julia del Amo, Rosa Polo, Santiago Moreno, et al.
AIDS (2022) Vol. 36, Iss. 15, pp. 2171-2179
Open Access | Times Cited: 17
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
Rocío Montejano, Fernando Calle, María Velasco, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e116-e125
Open Access | Times Cited: 16
Factors associated with SARS-CoV-2-related hospital outcomes among and between persons living with and without diagnosed HIV infection in New York State
Elizabeth M. Rosenthal, Eli S. Rosenberg, Wendy Patterson, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0268978-e0268978
Open Access | Times Cited: 14
Anti-SARS-CoV2 serological profile and associated factors in adults living with HIV followed at Departmental and Teaching Hospital of Borgou in 2022.
Attinsounon Cossi Angelo, Dovonou Comlan Albert, Alidjinou Kazali, et al.
Journal of Infectiology (2024) Vol. 6, Iss. 2, pp. 5-10
Open Access | Times Cited: 2
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV
Edgar T. Overton, Isabelle R. Weir, Markella V. Zanni, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2022) Vol. 90, Iss. 4, pp. 377-381
Open Access | Times Cited: 13
High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2
Valérie Pourcher, Lisa Belin, Cathia Soulié, et al.
AIDS (2022) Vol. 36, Iss. 11, pp. 1545-1552
Open Access | Times Cited: 13
Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients
Salum J. Lidenge, Dicle Yalcin, Sydney J. Bennett, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 448-448
Open Access | Times Cited: 2
SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study
Owen Ngalamika, Salum J. Lidenge, Marie Claire Mukasine, et al.
International Journal of Infectious Diseases (2022) Vol. 127, pp. 106-115
Open Access | Times Cited: 11
Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country
Odilon D. Kaboré, Armel Poda, Cheick Ahmed Ouattara, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0286665-e0286665
Open Access | Times Cited: 6
SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa
Humaira Lambarey, Melissa J. Blumenthal, Abeen Chetram, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1222-1222
Open Access | Times Cited: 10
HIV and COVID-19 Disease
Jacqueline Venturas
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 035-049
Closed Access | Times Cited: 5
SARS‐CoV‐2 testing, positivity, and factors associated with COVID‐19 among people with HIV across Europe in the multinational EuroSIDA cohort
O Fursa, Wendy Bannister, Bastian Neesgaard, et al.
HIV Medicine (2024) Vol. 25, Iss. 6, pp. 711-724
Open Access | Times Cited: 1
Unveiling the Quest: Crafting an Enzyme-Linked Immunosorbent Assay (ELISA) Technique to Uncover COVID-19 Antibodies
Nitin Deshpande, Poonam Suryawanshi, Srikanth Tripathy
Cureus (2024)
Open Access | Times Cited: 1
Incidence and Severity of SARS-CoV-2 Infection in HIV-Infected Individuals During the First Year of the Pandemic
David Rial‐Crestelo, Otilia Bisbal, Rebeca Font, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2021) Vol. 89, Iss. 5, pp. 511-518
Closed Access | Times Cited: 12
Drug Repurposing and Observational Studies: The Case of Antivirals for the Treatment of COVID-19
Miguel A. Hernán, Julia del Amo
Annals of Internal Medicine (2023) Vol. 176, Iss. 4, pp. 556-560
Open Access | Times Cited: 4
COVID-19 outcomes in people living with HIV: Peering through the waves
Thaís Lorenna Souza Sales, Maíra Viana Rego Souza-Silva, Polianna Delfino-Pereira, et al.
Clinics (2023) Vol. 78, pp. 100223-100223
Open Access | Times Cited: 4
No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands
Myrthe L. Verburgh, Marc van der Valk, Bart Rijnders, et al.
AIDS (2023) Vol. 37, Iss. 9, pp. 1481-1486
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top